Psoriasis Clinical Trial
A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)
Summary
The purpose of the study is to evaluate the ability of subjects with moderate to severe chronic plaque psoriasis (PSO) to safely and effectively self-inject bimekizumab at study start and 8 weeks after training in self-injection technique using a prefilled safety syringe or an auto-injector.
Eligibility Criteria
Inclusion Criteria:
Subject fulfills all inclusion criteria for the PS0014 [NCT03598790] study
Subject is considered reliable and capable of adhering to the DV0002 protocol (eg, able to understand and complete questionnaires, willing to self-inject, able to use investigational device according to the instructions for use (IFU), and able to adhere to the visit schedule) according to the judgment of the Investigator
Exclusion Criteria:
Subjects are not permitted to enroll in DV0002 if any of the PS0014 [NCT03598790] study exclusion criteria are met
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 27 Locations for this study
Phoenix Arizona, 85032, United States
Bakersfield California, 93309, United States
San Diego California, 92123, United States
San Luis Obispo California, 93405, United States
Santa Monica California, 90404, United States
Boca Raton Florida, 33486, United States
Miami Florida, 33144, United States
Ocala Florida, 34471, United States
Tampa Florida, 33624, United States
Alpharetta Georgia, 30022, United States
Skokie Illinois, 60077, United States
West Des Moines Iowa, 50265, United States
Overland Park Kansas, 66215, United States
Owensboro Kentucky, 42301, United States
Baton Rouge Louisiana, 70809, United States
Brighton Massachusetts, 02135, United States
Troy Michigan, 48084, United States
Saint Louis Missouri, 63117, United States
Portsmouth New Hampshire, 03801, United States
East Windsor New Jersey, 08520, United States
New York New York, 10029, United States
Rochester New York, 14623, United States
Portland Oregon, 97210, United States
Portland Oregon, 97223, United States
Johnston Rhode Island, 02919, United States
Houston Texas, 77598, United States
San Antonio Texas, 78213, United States
Edmonton , , Canada
Halifax , , Canada
Hamilton , , Canada
Markham , , Canada
Mississauga , , Canada
Montréal , , Canada
Québec City , , Canada
Richmond Hill , , Canada
Toronto , , Canada
Toronto , , Canada
Waterloo , , Canada
Windsor , , Canada
How clear is this clinincal trial information?